Ten genes validated with the TCGA database, including five DMGs (ESR1, EPB41L3, EDNRB,ID4, PLAC), might be used as biomarkers and therapeutic targets in the precise diagnosis and treatment of cervical cancer. This evidence concerns the gene ID4 and cervical carcinoma.